title: Regulatory properties of glutamate dehydrogenase from Sulfolobus solfataricus.
abstract: The purified glutamate dehydrogenase (GDH) from Sulfolobus solfataricus showed remarkable thermostability and retained 90-95% of the initial activity after incubation at -20 degrees C, 4 degrees C, and 25 degrees C for up to 6 months. Unlike mammalian GDHs, the activity of GDH from Sulfolobus solfataricus was not significantly affected by the presence of various allosteric effectors such as ADP, GTP, and leucine. Incubation of GDH with increasing concentration of o-phthalaldehyde resulted in a progressive decrease in enzyme activity, suggesting that the o-phthalaldehyde-modified lysine or cysteine is directly involved in catalysis. The inhibition was competitive with respect to both 2-oxoglutarate (Ki = 30 microM) and NADH (Ki = 100 microM), further supporting a possibility that the o-phthalaldehyde-modified residues may be directly involved at the catalytic site. The modification of GDH by the arginine-specific dicarbonyl reagent phenylglyoxal was also examined with the view that arginine residues might play a general role in the binding of coenzyme throughout the family of pyridine nucleotide-dependent dehydrogenases. The purified GDH was inactivated in a dose-dependent manner by phenylglyoxal. Either NADH or 2-oxoglutarate did not gave any protection against the inactivation caused by a phenylglyoxal. This result indicates that GDH saturated with NADH or 2-oxoglutarate is still open to attack by phenylglyoxal. Phenylglyoxal was an uncompetitive inhibitor (Ki = 5 microM) with respect to 2-oxoglutarate and a noncompetitive inhibitor (Ki = 6 microM) with respect to NADH. The above results suggests that the phenylglyoxal-modified arginine residues are not located at the catalytic site and the inactivation of GDH by phenylglyoxal might be due to a steric hindrance or a conformational change affected by the interaction of the enzyme with its inhibitor.
authors.affiliation: Department of Biochemistry, University of Ulsan College of Medicine, Seoul, Korea.
authors.forename: J Y
authors.initials: JY
authors.lastname: Ahn
authors.forename: K S
authors.initials: KS
authors.lastname: Lee
authors.forename: S Y
authors.initials: SY
authors.lastname: Choi
authors.forename: S W
authors.initials: SW
authors.lastname: Cho
mesh_terms: D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004795:Enzyme Stability; D005969:Glutamate Dehydrogenase / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D007656:Ketoglutaric Acids / Q000494:pharmacology; D007700:Kinetics; D008970:Molecular Weight; D010658:Phenylglyoxal / Q000494:pharmacology; D016944:Sulfolobus / Q000201:enzymology*; D013696:Temperature; D013997:Time Factors; D009764:o-Phthalaldehyde / Q000494:pharmacology
chemical_list: D004791:Enzyme Inhibitors; D007656:Ketoglutaric Acids; D009764:o-Phthalaldehyde; D005969:Glutamate Dehydrogenase; D010658:Phenylglyoxal